NCT06999187
Clinical Trial Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06999187
Title A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dren Bio
Indications
endometrial cancer
lung non-small cell carcinoma
stomach cancer
pancreatic ductal adenocarcinoma
cervical cancer
progesterone-receptor positive breast cancer
castration-resistant prostate carcinoma
estrogen-receptor positive breast cancer
gastroesophageal junction adenocarcinoma
head and neck squamous cell carcinoma
triple-receptor negative breast cancer
transitional cell carcinoma
Her2-receptor negative breast cancer
ovarian cancer
Therapies
DR-0202
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dren Investigational Site RECRUITING Denver Colorado 80218 United States Details
Dren Investigational Site RECRUITING Orlando Florida 32827 United States Details
Dren Investigational Site RECRUITING Sarasota Florida 34232 United States Details
Dren Investigational Site RECRUITING Huntersville North Carolina 28078 United States Details
Dren Investigational Site RECRUITING Oklahoma City Oklahoma 73104 United States Details
Dren Investigational Site RECRUITING Greenville South Carolina 29605 United States Details
Dren Investigational Site RECRUITING Austin Texas 78758 United States Details
Dren Investigational Site RECRUITING Dallas Texas 75230 United States Details
Dren Investigational Site RECRUITING San Antonio Texas 78229 United States Details
Dren Investigational Site RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field